World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
33373
World Ranking
10068
National Ranking
5185

C. Clifton Ling publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where C. Clifton Ling sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 407 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

C. Clifton Ling D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where C. Clifton Ling sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

C. Clifton Ling is a researcher affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their scholarly work spans various fields within medicine and molecular biology, as well as subfields including surgery, pediatrics, perinatology and child health, endocrinology, diabetes and metabolism, and genetics.

Their research focuses heavily on epigenetics and DNA methylation, pancreatic function and diabetes, birth, development and health, gestational diabetes research and management, adipose tissue and metabolism, liver disease diagnosis and treatment, and diet, metabolism, and disease.

Frequent publication venues for Ling's work include Diabetes, Nature Communications, Scientific Reports, Epigenomics, and Clinical Epigenetics. These journals reflect the core areas of their biomedical and clinical research interests.

Among their recent papers are:

  • "A framework for defining FLASH dose rate for pencil beam scanning" (2020, Medical Physics)
  • "Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?" (2022, Nature Reviews Endocrinology)
  • "Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes" (2020, Journal of Internal Medicine)
  • "Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes" (2020, Diabetes)
  • "Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes" (2020, Science Translational Medicine)

Ling collaborates frequently with researchers including Alexander Perfilyev, Allan Vaag, Karl Bacos, Sonia García-Calzón, and Emma Nilsson, demonstrating an extensive network within their research community.

Best Publications

  • Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

    C.Clifton Ling;John Humm;Steven Larson;Howard Amols

  • Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

    Michael J. Zelefsky;Steven A. Leibel;Paul Gaudin;Gerald J. Kutcher

  • High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

    Michael J Zelefsky;Zvi Fuks;Margie Hunt;Yoshiya Yamada

  • HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

    Michael J. Zelefsky;Zvi Fuks;Margie Hunt;Henry J. Lee

  • Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation ☆

    Joseph Hanley;Marc M. Debois;Dennis Mah;Gikas S. Mageras

  • Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

    Michael J Zelefsky;Zvi Fuks;Laura Happersett;Henry J Lee

  • Radiation-induced apoptosis: Relevance to radiotherapy

    William C. Dewey;Clifton C. Ling;Raymond E. Meyn

  • Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy.

    Thomas LoSasso;Chen-Shou Chui;C. Clifton Ling

  • The deep inspiration breath-hold technique in the treatment of inoperable non–small-cell lung cancer

    Kenneth E Rosenzweig;Joseph Hanley;Dennis Mah;Gig Mageras

  • Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning.

    E. C. Ford;G. S. Mageras;E. Yorke;C. C. Ling

  • Effect of Respiratory Gating on Quantifying PET Images of Lung Cancer

    Sadek A. Nehmeh;Yusuf E. Erdi;Clifton C. Ling;Kenneth E. Rosenzweig

  • Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose–volume histograms

    Andrew Jackson;Mark W Skwarchuk;Michael J Zelefsky;Didier M Cowen

  • Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.

    Mark W Skwarchuk;Andrew Jackson;Michael J Zelefsky;Ennapadam S Venkatraman

  • Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.

    C.Clifton Ling;Chandra Burman;Chen S. Chui;Gerald J. Kutcher

  • Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer

    Michael J. Zelefsky;Kent E. Wallner;C. Clifton Ling;Adam Raben

  • Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer

    Dennis Mah;Joseph Hanley;Kenneth E Rosenzweig;Ellen Yorke

  • Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

    Chandra Burman;Chen-Shou Chui;Gerald Kutcher;Steven Leibel

  • Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

    Ellen D. Yorke;Andrew Jackson;Kenneth E. Rosenzweig;Scott A. Merrick

  • Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

    Margie A Hunt;Michael J Zelefsky;Suzanne Wolden;Chen-Shou Chui

  • Clinically relevant optimization of 3-D conformal treatments.

    R. Mohan;G. S. Mageras;B. Baldwin;L. J. Brewster

Frequent Co-Authors

Zvi Fuks
Zvi Fuks Memorial Sloan Kettering Cancer Center
Steven A. Leibel
Steven A. Leibel Memorial Sloan Kettering Cancer Center
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
Gloria C. Li
Gloria C. Li Memorial Sloan Kettering Cancer Center
Jason A. Koutcher
Jason A. Koutcher Memorial Sloan Kettering Cancer Center
Nancy Y. Lee
Nancy Y. Lee Memorial Sloan Kettering Cancer Center
James A. Russell
James A. Russell Boston College
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens many doors, and online degrees now offer new, affordable options to enter or advance in the healthcare field. For those interested in healthcare administration, online medical billing and coding courses can provide a flexible and cost-effective entry point into the industry. These programs are ideal for students looking for a non-clinical role with strong job prospects.

If direct patient care is your goal, consider the cheap online fnp programs and cheapest rn to bsn online programs. These pathways help both aspiring and current nurses advance their education, expand their scope of practice, and increase their earning potential—often at a fraction of the traditional classroom cost.

For those drawn to leadership or research roles, online phd programs in nursing offer a route to the highest levels of the profession. Online study makes these advanced degrees more accessible, allowing you to balance work, family, and study as you grow your career in medicine.

Best Scientists Citing C. Clifton Ling

Trending Scientists

Recently Published Articles